U.S. Biobank Market Size & Outlook, 2023-2030
U.S. biobank market, 2018-2030 (US$M)
Related Markets
U.S. biobank market highlights
- The U.S. biobank market generated a revenue of USD 16,233.5 million in 2023 and is expected to reach USD 26,229.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
- In terms of segment, biobanking equipment was the largest revenue generating product in 2023.
- LIMS is the most lucrative product segment registering the fastest growth during the forecast period.
Biobank market data book summary
| Market revenue in 2023 | USD 16,233.5 million |
| Market revenue in 2030 | USD 26,229.9 million |
| Growth rate | 7.1% (CAGR from 2023 to 2030) |
| Largest segment | Biobanking equipment |
| Fastest growing segment | LIMS |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biobanking Equipment, Biobanking Consumables, LIMS |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH |
Other key industry trends
- In terms of revenue, U.S. accounted for 21.2% of the global biobank market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. biobank market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 16,851.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biobank Market Scope
Biobank Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. biobank market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biobank market will help companies and investors design strategic landscapes.
Biobanking equipment was the largest segment with a revenue share of 77.41% in 2023. Horizon Databook has segmented the U.S. biobank market based on biobanking equipment, biobanking consumables, lims covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is considered a highly competitive and mature market for biobanks. The players in this market space are not limited to pharma and biotech companies but extended to universities and hospitals.
For instance, in March 2020, Columbia University, along with the New York-Presbyterian Hospital, established a COVID-19 biobank to accelerate research studies.
Furthermore, in April 2020, Biogen, Inc., in collaboration with Partners HealthCare and Broad Institute of MIT, announced plans to build a COVID-19 biobank.
Reasons to subscribe to U.S. biobank market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. biobank market databook
-
Our clientele includes a mix of biobank market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biobank market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biobank market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. biobank market size, by product, 2018-2030 (US$M)
U.S. Biobank Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
